Partners HealthCare to fully integrate its EHR system with MassPAT
Category: #health  By Mateen Dalal  Date: 2019-03-16
  • share
  • Twitter
  • Facebook
  • LinkedIn

Partners HealthCare to fully integrate its EHR system with MassPAT

Partners Healthcare has now become the first healthcare network to have the tool immediately available to doctors at the point-of-care in Massachusetts.

Partners HealthCare, the Boston-based non-profit hospital and physicians network, has reportedly declared that it has fully-integrated with the Commonwealth of Massachusetts’ Prescription Awareness Tool (MassPAT) in its EHR (electronic health record) system.

Reportedly, Partners Healthcare has now become the first healthcare network to have the tool immediately available to doctors at the point-of-care in Massachusetts.

Commissioner of Public Health, Massachusetts, Monica Bharel, MD, MPH, was reportedly quoted saying that a vital aspect of preventing over-prescription of opioids has ensured providers have an accurate detail of prescription history of patients. MassPAT is a crucial aspect of the Commonwealth’s strategy to connect and support healthcare providers and having the Partners HealthCare system focused and fully integrated on ensuring that clinicians get access to the tool which would be a significant advancement in the collective efforts of both the firms to prevent the opioid epidemic, Bharel further added.

According to a press release by Partners HealthCare, Massachusetts Governor Charlie Baker had inked the historic legislation which created MassPAT in the year 2016. The state was one of the firsts in the country to instruct that all prescribers verify the prescription drug monitoring program (PDMP) before prescribing Schedule III or II substances and enforce a limit of seven days on first-time opioids prescriptions to patients.

Chief Quality and Safety Officer at Partners HealthCare, Thomas Sequist, MD, MPH, reportedly commented that the firm is equipping its providers with more strong point-of-care access to the prescription drug monitoring program of the state to support responsible and safe treatment of pain and better manage substance abuse disorder. Providers of Partners HealthCare are better informed about their patient’s medication use by examining the prescription information of patients in MassPAT and can prevent duplication of drug therapies and can further coordinate care by interacting with other prescribers to enhance clinical outcomes, Sequist further added.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Merck to acquire cancer drug maker Peloton Therapeutics for $1.05Bn
Merck to acquire cancer drug maker Peloton Therapeutics for $1.05Bn
By Mateen Dalal

The acquisition would help Merck strengthen its presence in the renal cell carcinoma space and support its cancer drug portfolio. U.S. pharmaceutical conglomerate, Merck & Co. Inc. has recently agreed to purchase Dallas based Peloton Therapeutic...

Ikea invests in India’s one-stop interior design platform Livspace
Ikea invests in India’s one-stop interior design platform Livspace
By Mateen Dalal

The interior design platform had raised over $70 million last year with investment from TPG Growth & Goldman Sachs. The investment is Ikea’s first such deal in India, however it isn’t the company’s dalliance in India’s ...

BioXcel unveils data from Phase 1 study of receptor agonist BXCL501
BioXcel unveils data from Phase 1 study of receptor agonist BXCL501
By Mateen Dalal

Sublingual administration of BXCL501 had achieved drug exposures that will be therapeutic for the acute treatment of agitation Reports confirm that BioXcel Therapeutics (BTI) has recently presented data from its Phase 1 pharmacokinetic (bioavailabil...